In Angola, cancer incidence and mortality is increasing dramatically, with breast cancer at its head. Among others, key challenges are limited cancer awareness, diagnosis, lack of breast surgical expertise, procurement hurdles and a limited healthcare budget.

In 2017 when Roche launched this activity in Angola and started engaging with HCPs, HCO and local authorities to evaluate the state of oncology in Angola. The TRACMA Project aims to solve access hurdles of breast cancer patients in Angola and provide diagnostic and treatment to the patients who can benefit from them. Also to advocate for stronger investment in NCDs and Oncology.

In the engagements with the National Cancer Institute, TRACMA project (Programa de Tratamento do Cancro de Mama em Angola – in Portuguese) was born.

The project is now scaling up to other Angolan Provinces and to other Portuguese-Speaking African Countries like Cape Verde and Mozambique, with the aim to increase access to our innovative treatments for patients in Sub-Saharan Africa while compliantly creating a long-term sustainable business opportunity for Roche and driving substantial impact for patients.